Arkolith/Insider Trading/PTGX/Form 4

Molina Arturo MD

Chief Medical OfficerProtagonist Therapeutics, Inc (PTGX) · full profile →Form 4 · filed Mar 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.6M
Net Open-Market Flow
-$1.6M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 26, 2026Sell(S)15K$104.79$1.6M84K
Mar 26, 2026Option exercise(M)15K$8.04$121K99K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 26, 2026Option exercise(M)15K—$051K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-036319) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML